title: Evolution of HIV-1 multidrug-resistant genotypes during combination therapy and after the cessation of antiretroviral drugs.
authors.affiliation: Laboratoire de Virologie, UF SIDA, CHRU La Timone, France.
authors.forename: N
authors.initials: N
authors.lastname: Yahi
authors.forename: C
authors.initials: C
authors.lastname: Tourrès
authors.forename: N
authors.initials: N
authors.lastname: Tivoli
authors.forename: P
authors.initials: P
authors.lastname: Colson
authors.forename: C
authors.initials: C
authors.lastname: Dhiver
authors.forename: A M
authors.initials: AM
authors.lastname: Quinson
authors.forename: C
authors.initials: C
authors.lastname: Tamalet
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004352:Drug Resistance, Microbial / Q000235:genetics; D018432:Drug Resistance, Multiple / Q000235:genetics; D004359:Drug Therapy, Combination; D019143:Evolution, Molecular; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology*; D054303:HIV Reverse Transcriptase / Q000235:genetics; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D009154:Mutation; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D054303:HIV Reverse Transcriptase